Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and liver disease: mechanistic and clinical perspectives
Thomas Marjot, Gwilym J. Webb, A. Sidney Barritt, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 5, pp. 348-364
Open Access | Times Cited: 339

Showing 1-25 of 339 citing articles:

Global burden of liver disease: 2023 update
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 516-537
Open Access | Times Cited: 865
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 4, pp. 284-296
Closed Access | Times Cited: 398
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 273
Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions
Yuanbin Liu, Mingkai Chen
World Journal of Gastroenterology (2022) Vol. 28, Iss. 41, pp. 5910-5930
Open Access | Times Cited: 91
The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It
Jonaid Ahmad Malik, Sakeel Ahmed, Mrunal Shinde, et al.
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 5, pp. 3586-3599
Open Access | Times Cited: 87
COVID-19 and liver disease
Jean‐François Dufour, Thomas Marjot, Chiara Becchetti, et al.
Gut (2022) Vol. 71, Iss. 11, pp. 2350-2362
Closed Access | Times Cited: 71
Drug induced liver injury – a 2023 update
Rebecca Allison, Asha Guraka, Isaac Thom Shawa, et al.
Journal of Toxicology and Environmental Health Part B (2023) Vol. 26, Iss. 8, pp. 442-467
Open Access | Times Cited: 45
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis
Matthew J. McConnell, Reiichiro Kondo, Nao Kawaguchi, et al.
Hepatology Communications (2021) Vol. 6, Iss. 2, pp. 255-269
Open Access | Times Cited: 56
Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury
Min Liu, Qiong Huang, Yan Zhu, et al.
Materials Today Bio (2022) Vol. 13, pp. 100215-100215
Open Access | Times Cited: 55
SARS-CoV-2 infection and liver involvement
Mingjia Luo, María Pilar Ballester, Ugo Soffientini, et al.
Hepatology International (2022) Vol. 16, Iss. 4, pp. 755-774
Open Access | Times Cited: 43
Asialoglycoprotein receptor 1 promotes SARS-CoV-2 infection of human normal hepatocytes
Xinyi Yang, Xu Zheng, Yuqi Zhu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 10
COVID-19 and Clostridioides difficile Coinfection Analysis in the Intensive Care Unit
M Stoian, Adina Andone, Alina Boeriu, et al.
Antibiotics (2024) Vol. 13, Iss. 4, pp. 367-367
Open Access | Times Cited: 8
SARS‐CoV‐2 Productively Infects Human Hepatocytes and Induces Cell Death
Chunkyu Ko, Cho‐Chin Cheng, Daniele Mistretta, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access | Times Cited: 1
Dose determination of VV116 in COVID-19 patients with severe liver dysfunction: a case report
Liu Yang, Wenwen Jiang, Jianqing Deng, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 1
Characteristic immune cell interactions in livers of children with acute hepatitis revealed by spatial single-cell analysis identify a possible postacute sequel of COVID-19
Felix Röttele, Andreas Zollner, Carolin Mogler, et al.
Gut (2025), pp. gutjnl-333880
Closed Access | Times Cited: 1
Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients
Shobi Veleri
Experimental Brain Research (2021) Vol. 240, Iss. 1, pp. 9-25
Open Access | Times Cited: 55
Potential Effects of Coronaviruses on the Liver: An Update
Xinyi Wang, Jianyong Lei, Zhihui Li, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 53
Impact of COVID‐19 in Liver Disease Progression
Miguel Ángel Martı́nez, Sandra Franco
Hepatology Communications (2021) Vol. 5, Iss. 7, pp. 1138-1150
Open Access | Times Cited: 49
Alcohol‐Associated Liver Disease Before and After COVID‐19—An Overview and Call for Ongoing Investigation
Andrew M. Moon, Brenda Curtis, Pranoti Mandrekar, et al.
Hepatology Communications (2021) Vol. 5, Iss. 9, pp. 1616-1621
Open Access | Times Cited: 47
SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination
Andrew M. Moon, Gwilym J. Webb, Ignacio García‐Juárez, et al.
Hepatology Communications (2021) Vol. 6, Iss. 4, pp. 889-897
Open Access | Times Cited: 44
Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method
Rolf Teschke, Nahúm Méndez‐Sánchez, Axel Eickhoff
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4828-4828
Open Access | Times Cited: 37
Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases
Athanasios‐Dimitrios Bakasis, Kleopatra Bitzogli, Dimitrios Mouziouras, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 207-207
Open Access | Times Cited: 36
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States
Donghee Kim, Omar Alshuwaykh, Brittany B. Dennis, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 10, pp. 2307-2316.e3
Open Access | Times Cited: 33
Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID‐19: a self‐controlled case series study
Carlos King Ho Wong, Ivan Chi Ho Au, Wing Yiu Cheng, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 1, pp. 121-130
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top